| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.34 | 4e-14 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.38 | 5e-12 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.38 | 1e-11 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-08 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-06 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.21 | 4e-06 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-05 |